ICON EBITDA 2010-2025 | ICLR
ICON annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- ICON EBITDA for the quarter ending March 31, 2025 was $0.316B, a 27.41% decline year-over-year.
- ICON EBITDA for the twelve months ending March 31, 2025 was $1.467B, a 9.15% decline year-over-year.
- ICON 2024 annual EBITDA was $1.586B, a 2.87% increase from 2023.
- ICON 2023 annual EBITDA was $1.542B, a 13% increase from 2022.
- ICON 2022 annual EBITDA was $1.365B, a 96.79% increase from 2021.
| ICON Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,586 |
| 2023 | $1,542 |
| 2022 | $1,365 |
| 2021 | $694 |
| 2020 | $458 |
| 2019 | $525 |
| 2018 | $439 |
| 2017 | $400 |
| 2016 | $371 |
| 2015 | $339 |
| 2014 | $255 |
| 2013 | $167 |
| 2012 | $111 |
| 2011 | $78 |
| 2010 | $126 |
| 2009 | $149 |
| ICON Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $316 |
| 2024-12-31 | $381 |
| 2024-09-30 | $391 |
| 2024-06-30 | $379 |
| 2024-03-31 | $435 |
| 2023-12-31 | $406 |
| 2023-09-30 | $419 |
| 2023-06-30 | $355 |
| 2023-03-31 | $362 |
| 2022-12-31 | $346 |
| 2022-09-30 | $386 |
| 2022-06-30 | $322 |
| 2022-03-31 | $312 |
| 2021-12-31 | $284 |
| 2021-09-30 | $146 |
| 2021-06-30 | $128 |
| 2021-03-31 | $136 |
| 2020-12-31 | $137 |
| 2020-09-30 | $111 |
| 2020-06-30 | $87 |
| 2020-03-31 | $123 |
| 2019-12-31 | $139 |
| 2019-09-30 | $133 |
| 2019-06-30 | $129 |
| 2019-03-31 | $125 |
| 2018-12-31 | $117 |
| 2018-09-30 | $115 |
| 2018-06-30 | $99 |
| 2018-03-31 | $109 |
| 2017-12-31 | $106 |
| 2017-09-30 | $101 |
| 2017-06-30 | $92 |
| 2017-03-31 | $100 |
| 2016-12-31 | $100 |
| 2016-09-30 | $92 |
| 2016-06-30 | $88 |
| 2016-03-31 | $91 |
| 2015-12-31 | $91 |
| 2015-09-30 | $86 |
| 2015-06-30 | $82 |
| 2015-03-31 | $81 |
| 2014-12-31 | $66 |
| 2014-09-30 | $73 |
| 2014-06-30 | $61 |
| 2014-03-31 | $54 |
| 2013-12-31 | $41 |
| 2013-09-30 | $45 |
| 2013-06-30 | $42 |
| 2013-03-31 | $141 |
| 2012-12-31 | $29 |
| 2012-09-30 | $31 |
| 2012-06-30 | $28 |
| 2012-03-31 | $113 |
| 2011-12-31 | $17 |
| 2011-09-30 | $11 |
| 2011-06-30 | $25 |
| 2011-03-31 | $101 |
| 2010-12-31 | $121 |
| 2010-09-30 | $26 |
| 2010-06-30 | $34 |
| 2010-03-31 | $36 |
| 2009-12-31 | $39 |
| 2009-09-30 | $39 |
| 2009-06-30 | $37 |
| 2009-03-31 | $34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.566B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.269B | 25.37 |
| Elevance Health (ELV) | United States | $85.392B | 11.02 |
| CVS Health (CVS) | United States | $79.000B | 9.82 |
| Cencora (COR) | United States | $56.052B | 19.50 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $22.013B | 0.00 |
| BioMerieux (BMXMF) | France | $15.348B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.094B | 0.00 |
| CochLear (CHEOY) | Australia | $11.426B | 0.00 |
| Revvity (RVTY) | United States | $10.766B | 18.53 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| Doximity (DOCS) | United States | $9.641B | 44.90 |
| Avantor (AVTR) | United States | $8.879B | 12.90 |
| HealthEquity (HQY) | United States | $8.778B | 43.18 |
| Medpace Holdings (MEDP) | United States | $8.445B | 22.43 |
| Sonic Healthcare (SKHHY) | Australia | $8.256B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.692B | 13.11 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.050B | 23.88 |
| BrightSpring Health Services (BTSG) | United States | $4.042B | 37.42 |
| Sotera Health (SHC) | United States | $3.463B | 19.68 |
| Alignment Healthcare (ALHC) | United States | $2.978B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.933B | 38.14 |
| Concentras Parent (CON) | United States | $2.751B | 15.90 |
| Organon (OGN) | United States | $2.379B | 2.53 |
| Ardent Health Partners (ARDT) | United States | $2.120B | 9.04 |
| GeneDx Holdings (WGS) | United States | $1.998B | 76.94 |
| Premier (PINC) | United States | $1.885B | 14.31 |
| Progyny (PGNY) | United States | $1.822B | 40.09 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.179B | 8.97 |
| Establishment Labs Holdings (ESTA) | $1.038B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.978B | 15.27 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| Nutex Health (NUTX) | United States | $0.921B | 13.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.617B | 4.15 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.17 |
| LifeMD (LFMD) | United States | $0.521B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.479B | 10.78 |
| SBC Medicals (SBC) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.278B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |